The Tile Shop Debuts Exclusive Designer Tile Collection With Artist Laura Park
MINNEAPOLIS, July 30, 2025 (GLOBE NEWSWIRE) — The Tile Shop (Nasdaq: TTSH), a specialty retailer of natural stone and man-made tiles, is proud to announce the launch of an exclusive new collaboration with acclaimed artist and designer Laura Park. The Tile Shop x Laura Park, available now, showcases Park's signature bold brushwork, joyful color palettes, and modern abstract style across a fresh, artistic range of tiles crafted to bring warmth and creativity to every corner of the home.
'We are thrilled to partner with the incredibly talented Laura Park,' said Kirsty Froelich, Senior Director of Design and Product Development at The Tile Shop. 'Her stunning artwork comes to life beautifully on tile, bringing a rich, artistic, and coastal vibe that instantly elevates any space. Her captivating collection is expansive, giving our customers the opportunity to design the perfect space—filled with beauty, inspiration, and joyful character.'
Available now at all U.S. Tile Shop showrooms and online at tileshop.com , each piece in the collection captures the energy and movement of Park's original artworks in tile formats that translate effortlessly to walls and floors. With a carefully curated palette of uplifting yet versatile tones—ranging from ocean-inspired blues to neutral taupes and whites—these tiles were created to mix and match across rooms and design styles, from bold feature walls to quiet, artful accents.
'I'm so excited to partner with The Tile Shop and see my designs take on new life in tile, because tile has the power to truly define a space,' said Park. 'My tiles are designed to work together and offer flexibility in layout and design. I hope people use them to create spaces that inspire them and bring joy.'
Park, a self-taught artist whose work is rooted in a lifelong love of interior design, textiles, and color, approached the collection with the intention of turning tile into art for the home. From bathrooms and kitchens to living areas and entryways, the collection offers options for every surface—and every style of self-expression.
'For me, art is about bringing joy into the everyday,' said Park. 'Every tile in the collection is meant to brighten your space with beauty and cheer.'
In addition to The Tile Shop x Laura Park, the retailer's growing portfolio of exclusive collections includes collaborations with celebrated designers Alison Victoria, Jeffrey Alan Marks, Kelli Fontana, Nikki Chu, and Nate Berkus (launching fall 2026), as well as heritage brands Laura Ashley and Morris & Co.
ABOUT LAURA PARK
Laura Park's signature patterns bring her original artwork to life, with bold brushstrokes and vibrant colors weaving together into playful, abstract prints. A self-taught artist, Laura's creative journey began in her grandmother's art studio and evolved through her travels and experience in the world of interiors. In 2016, she founded Laura Park Designs, transforming her digital patterns into textiles. What started as a collection of signature pillows has since blossomed into a diverse range of products, including bedding, fabric, wallpaper, lifestyle accessories, and tabletop décor—each piece a reflection of Laura's unique blend of artistry and modern design. Explore the full collection at lauraparkdesigns.com .
ABOUT THE TILE SHOP
Tile Shop Holdings, Inc. (Nasdaq: TTSH) is a leading specialty retailer of natural stone, man-made and luxury vinyl tiles, setting and maintenance materials, and related accessories in the United States. The Tile Shop offers a wide selection of high-quality products, exclusive designs, knowledgeable staff and exceptional customer service in an extensive showroom environment. The Tile Shop currently operates 141 stores in 31 states and the District of Columbia.
The Tile Shop is a proud member of the American Society of Interior Designers (ASID), National Association of Homebuilders (NAHB), National Kitchen and Bath Association (NKBA), and the National Tile Contractors Association (NTCA). For more information, visit www.tileshop.com . Join The Tile Shop (#thetileshop) on Instagram, TikTok, Facebook, Pinterest and YouTube.
Tile Shop Media Contact:
[email protected]
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9a646fb1-41f5-4e2f-8989-c4f62b24a172
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J., August 01, 2025--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the "Freedom System") currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit View source version on Contacts Investor Contact: Louisa Smithinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
29 minutes ago
- Business Wire
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) ('KORU Medical' or the 'Company'), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced inducement equity awards to Adam Kalbermatten, Chief Commercial Officer, pursuant to his previously announced employment agreement with the Company dated as of June 30, 2025. Mr. Kalbermatten was granted nonqualified stock options on August 1, 2025 to purchase 600,000 shares of the Company's common stock at an exercise price of $3.44 per share. In addition, on July 28, 2025, his start date, Mr. Kalbermatten received 300,000 restricted shares of the Company's common stock. Each of these awards are subject to vesting 25% on each anniversary of their grant date, subject to accelerated vesting and the other terms and conditions of the respective award agreements entered into between Mr. Kalbermatten and the Company. The Compensation Committee of the Company's Board of Directors approved the awards as an inducement material to Mr. Kalbermatten's employment in accordance with Nasdaq Listing Rule 5635(c)(4). About KORU Medical Systems KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the 'Freedom System') currently includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Services and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit
Hamilton Spectator
30 minutes ago
- Hamilton Spectator
Wall Street falls the most since May after employers slash hiring and tariffs roll out
The U.S. stock market had its worst day since May on Friday after the government reported a sharp slowdown in hiring and President Donald Trump imposed sweeping tariffs on imports from a number of U.S. trading partners. The S&P 500 fell 1.6%, its biggest decline since May 21 and its fourth straight loss. The index is also posted a 2.4% loss for the week, marking a sharp shift from last week's record-setting streak of gains. The Dow Jones Industrial Average fell 1.2%, while the Nasdaq composite fell 2.2%. Worries on Wall Street about a weakening economy were heavily reinforced by the latest report on job growth in the U.S. Employers added just 73,000 jobs in July. That is sharply lower than economists expected. The Labor Department also reported that revisions shaved a stunning 258,000 jobs off May and June payrolls. Markets also reacted to the latest tariff news . President Donald Trump announced tariff rates on dozens of countries and pushed back the scheduled effective date to Aug. 7, adding more uncertainty to the global trade picture.
